Raymond James analyst John Ransom last night initiated coverage of Oscar Health with an Outperform rating and $20 price target. Oscar is a technology enabled and consumer oriented health insurance company, with a focus on the individual and small group markets, primarily selling health plans through the Health Insurance Exchange, the analyst tells investors in a research note. The analyst believes current share levels offer an attractive risk/reward as the new CEO will “help unlock embedded earnings power.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSCR: